excellent post - from the 1st video- Dr Faro 's mentioning
excellent post - from the 1st video- Dr Faro 's mentioning of handwashing -and re ties spreading germs from patient to patient before dr's began wearing closed whitecoats -and our various posts about resistance to new regimens-both active resistance by established players w an economic motive to stop new regimen- and passive resistance of routine inertia-
reminds me of a novel I read many decades ago based on a true story about a dr who discovered that dr's lack of washing their hands prior to WW1 and modern plumbing- between patients- even going from cadavers to delivering babies -resulting in high infant mortality- and then when he became an administrator of a hospital he finally had the power to do something about it -ordering drs to wash between patients -greatly reducing patient mortality- and then the practice spread.
The novel was called the citadel and i thought it was set in ca 1910 -similar in some respects to the a j cronin novel of 1937 -maybe it was the same -though seem to be differences
but nanologix is dealing w the same process -discover problem,devise solution-get the word out and overcome active and passive resistance to new regimen- once hospitals start seeing the difference in care resulting from nnlx 's rapid etc tests, then hopefully the same snowball effect,esp if patients choose hospitals who 1st start using the rapid tests
getting test results for gbs in 30 min and susceptibility tests overnight sounds a lot better than 5 days. both for mortality and the $261,000 lifetime cost per patient born w gbs- did he say 30%? of women w gbs- i know some cultures are as high as 75% for various pathogens
so is the problem big enough to overcome resistance in a reasonable period of time-and this of course is just re 1 of many conditions nnlx has much faster tests than those currently being used- just some ramblings of somebody who has no expertise in this field
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...
Continue Reading
Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...
Continue Reading
MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...
Continue Reading
Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...
Continue Reading
Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...
Continue Reading
Here's the scoop: ACG Metals Limited is stepping up the game, attempting to snag the Ke?kek gold project in a deal worth up to $7.85 million. This move, they say, is all about bolstering the future of their gold production—and squeezing every ounce out of that Gediktepe facility in Türkiye. It's like squeezing juice from a lemon that's still got a bit of life left....
Continue Reading
Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...
Continue Reading
Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...
Continue Reading
A New Powerhouse in the Nordic Consultancy Space September 7, 2026, will likely be etched into the annals of stock market moves, marking the day two titans, Multiconsult and Rejlers, decided to tie the knot. This isn't your average merger. We're talking about a calculated Pan-Nordic push that's been building, and now, well, it's paying off with a potential powerhouse of...
Continue Reading
Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...
Continue Reading
Top 5 Most Recently Viewed Articles
Corvex Management Invests in Whitbread PLC Corvex Management LP, associated with strategic investments, has made headlines recently by announcing its acquisition of a substantial economic interest in Whitbread PLC. The firm has accumulated around 10,221,246 share equivalents, accounting for approximately 6.05% of Whitbread's issued and outstanding ordinary share capital....
Continue Reading
Center for Vein Restoration Expands with New Clinic Center for Vein Restoration (CVR), recognized as America’s largest network of physician-led vein care facilities, is thrilled to announce the introduction of its latest clinic in Houston. As a leader in diagnosing and treating vein-related disorders, CVR is dedicated to broadening its services and providing exceptional...
Continue Reading
Sable Offshore Secures Significant Equity Financing Sable Offshore Corp. (NYSE:SOC), known for its expertise in crude oil and natural gas, has recently wrapped up an important private investment in public equity (PIPE) offering. The company raised roughly $150 million by issuing 7.5 million new shares. This crucial deal was finalized on a noteworthy date, following...
Continue Reading
Anavex Life Sciences Engages at the Evercore ISI Conference NEW YORK, Dec. 02, 2024 -- Anavex Life Sciences Corp. (Nasdaq: AVXL), a pioneering biopharmaceutical company focused on developing innovative therapies for neurological conditions, has an exciting opportunity at the upcoming 7th Annual Evercore ISI HealthCONx Conference happening soon. Fireside Chat Details Dr....
Continue Reading
Bellevue Life Sciences Secures Crucial $300,000 Loan Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) has made a significant move in its financial strategy by entering into a definitive agreement with OSR Holdings Co., Ltd. This agreement involves a loan of $300,000, which is documented by a promissory note. This arrangement underscores the company's commitment to...
Continue Reading